Nifedipine improves endothelial function role of endothelial progenitor cells

被引:54
作者
Sugiura, Tomonori [1 ,2 ,3 ,4 ]
Kondo, Takahisa [1 ]
Kureishi-Bando, Yasuko [1 ]
Numaguchi, Yasushi [1 ]
Yoshida, Osamu [1 ]
Dohi, Yasuaki [2 ]
Kimura, Genjiro [2 ]
Ueda, Ryuzo [3 ,4 ]
Rabelink, Ton J. [5 ]
Murohara, Toyoaki [1 ]
机构
[1] Nagoya Univ, Grad Sch Med, Dept Cardiol, Showa Ku, Nagoya, Aichi 4668550, Japan
[2] Nagoya City Univ, Grad Sch Med Sci, Dept Cardiorenal Med & Hypertens, Nagoya, Aichi, Japan
[3] Nagoya City Univ, Grad Sch Med Sci, Dept Internal Med, Nagoya, Aichi, Japan
[4] Nagoya City Univ, Grad Sch Med Sci, Dept Mol Sci, Nagoya, Aichi, Japan
[5] Leiden Univ, Med Ctr, Dept Hypertens & Nephrol, Leiden, Netherlands
关键词
hypertension; endothelial function; endothelial progenitor cell; nifedipine; oxidative stress;
D O I
10.1161/HYPERTENSIONAHA.108.111914
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Nifedipine has been shown to improve endothelial function. Recent studies have indicated that endothelial function is correlated with the number of circulating endothelial progenitor cells ( EPCs), but it is unclear whether nifedipine affects the number and function of EPCs. The aims of this study were to determine the effects of nifedipine on the number and function of EPCs and to investigate the relationship between improvement of endothelial function and EPC numbers in patients with hypertension. Stage 1 hypertensive men ( n = 37) were randomly divided into the nifedipine group and the control untreated group. The nifedipine group was administered slow- release nifedipine ( 20 mg) once daily. At baseline and after 4 weeks, flow-mediated dilation, blood pressure, biochemical data, and number of circulating CD34+ CD133+ progenitor cells and EPCs were measured. The direct effects of nifedipine on EPC number and function were assessed in vitro. In the nifedipine group, flow-mediated dilation and the numbers of circulating CD34+ CD133+ progenitor cells and EPCs were increased, along with a decrease of serum malondialdehyde low-density lipoprotein. The improvement of flow-mediated dilation by nifedipine was correlated with the increase of circulating CD34+ CD133+ progenitor cells. Nifedipine also improved angiogenesis- related functions of EPCs ( differentiation, migration, and resistance to oxidative stress) in vitro. Thus, nifedipine improved endothelial function and EPC function in stage 1 hypertensive subjects. The latter action may be mediated by reduction of oxidative stress and suppression of EPC apoptosis. These results demonstrate that nifedipine preserves endothelial integrity in patients with hypertension, at least partly, by enhancing EPC numbers and activity.
引用
收藏
页码:491 / 498
页数:8
相关论文
共 39 条
[1]   Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells [J].
Aicher, A ;
Heeschen, C ;
Mildner-Rihm, C ;
Urbich, C ;
Ihling, C ;
Technau-Ihling, K ;
Zeiher, AM ;
Dimmeler, S .
NATURE MEDICINE, 2003, 9 (11) :1370-1376
[2]   Isolation of putative progenitor endothelial cells for angiogenesis [J].
Asahara, T ;
Murohara, T ;
Sullivan, A ;
Silver, M ;
vanderZee, R ;
Li, T ;
Witzenbichler, B ;
Schatteman, G ;
Isner, JM .
SCIENCE, 1997, 275 (5302) :964-967
[3]   Effect of nifedipine and cerivastatin on coronary endothelial function in patients with coronary artery disease -: The ENCORE I study (Evaluation of nifedipine and cerivastatin on recovery of coronary endothelial function) [J].
Azancot, I ;
Balbi, M ;
Bonnier, JJRM ;
Desmet, W ;
Diederich, KW ;
Drexel, H ;
Dubois-Rande, J ;
Etbel, R ;
Ribeiro, VD ;
Glogar, H ;
Hanrath, P ;
Hess, OM ;
Heyer, G ;
Hugenholtz, PG ;
Lafont, A ;
Lüscher, TF .
CIRCULATION, 2003, 107 (03) :422-428
[4]   Nifedipine increases endothelial nitric oxide bioavailability by antioxidative mechanisms [J].
Berkels, R ;
Egink, G ;
Marsen, TA ;
Bartels, H ;
Roesen, R ;
Klaus, W .
HYPERTENSION, 2001, 37 (02) :240-245
[5]   Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response [J].
Bots, ML ;
Westerink, J ;
Rabelink, TJ ;
de Koning, EJP .
EUROPEAN HEART JOURNAL, 2005, 26 (04) :363-368
[6]   Synergistic antihypertensive effects of nifedipine on endothelium - Concurrent release of NO and scavenging of superoxide [J].
Brovkovych, V ;
Kalinowski, L ;
Muller-Peddinghaus, R ;
Malinski, T .
HYPERTENSION, 2001, 37 (01) :34-39
[7]   Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT) [J].
Brown, MJ ;
Palmer, CR ;
Castaigne, A ;
de Leeuw, PW ;
Mancia, G ;
Rosenthal, T ;
Ruilope, LM .
LANCET, 2000, 356 (9227) :366-372
[8]   Endothelial dysfunction in cardiovascular diseases - The role of oxidant stress [J].
Cai, H ;
Harrison, DG .
CIRCULATION RESEARCH, 2000, 87 (10) :840-844
[9]   Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery - A report of the International Brachial Artery Reactivity Task Force [J].
Corretti, MC ;
Anderson, TJ ;
Benjamin, EJ ;
Celermajer, D ;
Charbonneau, F ;
Creager, MA ;
Deanfield, J ;
Drexler, H ;
Gerhard-Herman, M ;
Herrington, D ;
Vallance, P ;
Vita, J ;
Vogel, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (02) :257-265
[10]   Endothelial function and dysfunction - Testing and clinical relevance [J].
Deanfield, John E. ;
Halcox, Julian P. ;
Rabelink, Ton J. .
CIRCULATION, 2007, 115 (10) :1285-1295